Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skin

Exp Cell Res. 2016 Jul 15;345(2):247-54. doi: 10.1016/j.yexcr.2016.05.004. Epub 2016 May 17.

Abstract

Interleukin (IL)-22 is a pro-inflammatory cytokine driving the progression of the psoriatic lesion with other cytokines, as Tumor Necrosis Factor (TNF)-alpha and IL-17. Our study was aimed at evaluating the early effect of IL-22 alone or in combination with TNF-alpha and IL-17 by immunofluorescence on i) keratinocyte (KC) proliferation, ii) terminal differentiation biomarkers as keratin (K) 10 and 17 expression, iii) intercellular junctions. Transmission electron microscopy (TEM) analysis was performed. A model of human skin culture reproducing a psoriatic microenvironment was used. Plastic surgery explants were obtained from healthy young women (n=7) after informed consent. Fragments were divided before adding IL-22 or a combination of the three cytokines, and harvested 24 (T24), 48 (T48), and 72 (T72)h later. From T24, in IL-22 samples we detected a progressive decrease in K10 immunostaining in the spinous layer paralleled by K17 induction. By TEM, after IL-22 incubation, keratin aggregates were evident in the perinuclear area. Occludin immunostaining was not homogeneously distributed. Conversely, KC proliferation was not inhibited by IL-22 alone, but only by the combination of cytokines. Our results suggest that IL-22 affects keratinocyte terminal differentiation, whereas, in order to induce a proliferation impairment, a more complex psoriatic-like microenvironment is needed.

Keywords: Interleukin-17; Keratin 10; Keratin 17; Transmission electron microscopy; Tumor necrosis factor alpha.

MeSH terms

  • Adult
  • Biomarkers / metabolism
  • Cell Adhesion / drug effects
  • Cell Differentiation / drug effects*
  • Cell Proliferation / drug effects
  • Epidermis / drug effects
  • Epidermis / metabolism
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Interleukin-22
  • Interleukins / pharmacology*
  • Keratinocytes / cytology*
  • Keratinocytes / drug effects
  • Keratinocytes / ultrastructure
  • Models, Biological*
  • Skin / cytology*
  • Young Adult

Substances

  • Biomarkers
  • Interleukins